Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.6500
-0.0450 (-6.47%)
At close: Mar 28, 2025, 4:00 PM
0.6200
-0.0300 (-4.62%)
After-hours: Mar 28, 2025, 7:53 PM EST
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 41 employees as of December 31, 2023. The number of employees increased by 3 or 7.89% compared to the previous year.
Employees
41
Change (1Y)
3
Growth (1Y)
7.89%
Revenue / Employee
n/a
Profits / Employee
-$681,610
Market Cap
12.56M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41 | 3 | 7.89% |
Dec 31, 2022 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLDI News
- 2 days ago - Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 20 days ago - Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform - GlobeNewsWire
- 4 weeks ago - Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 4 weeks ago - Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital - GlobeNewsWire
- 2 months ago - Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5 - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock - GlobeNewsWire